Purchase Order SPE2DP26P0178
- Not listed
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,112.95 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of varicella virus vaccine (SPE2D021D0004|SPE2D024F0535) and has an ultimate completion date of September 16, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and...
- The Defense Logistics Agency (DLA) issued a delivery order valued at $2,216.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Varivax vaccine with diluents. The award was made on November 18, 2025, with an ultimate completion date of November 19, 2025, under a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group will perform this work at its location in Park Ridge,...
- The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a delivery order to DMS Pharmaceutical Group Inc. for $5,926.60 to supply Varivax vaccine with diluents. The order, issued on September 10, 2025, with an ultimate completion date of September 15, 2025, utilizes a firm fixed-price contract type with no set-aside designation. Performance will occur at DMS Pharmaceutical Group's facility in Park Ridge, Illinois. This delivery order is issued under a larger...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against an indefinite delivery contract with the Defense Logistics Agency to provide varicella virus vaccine for $1,858.92. As a woman-owned small business, DMS Pharmaceutical Group will supply the vaccine to fulfill requirements at Defense Logistics Agency Troop Support Medical facilities. The delivery order was awarded on August 13, 2021 and requires completion by August 23, 2021. DMS Pharmaceutical Group holds...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $15,245.28 under an indefinite delivery contract with the Defense Logistics Agency to supply varicella virus vaccine. As a woman-owned small business, DMS Pharmaceutical Group will provide the vaccine to Defense Logistics Agency Troop Support Medical facilities located in Park Ridge, Illinois. The delivery order was awarded on February 21, 2019 and is to be completed by March 4, 2019. DMS Pharmaceutical Group...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,431.36 by the Defense Logistics Agency for the supply of Varivax vaccine with diluents. The contract, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a standard procurement action with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $23,706.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Varivax vaccine with diluents. The contract, issued on August 5, 2025, with an ultimate completion date of August 8, 2025, operates under a firm fixed-price delivery order structure with no set-aside designation. This delivery order falls under DMS...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,112.95 fixed-price with economic price adjustment contract is for the delivery of varicella virus vaccine, with a period of performance running through July 1, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows...
- The Defense Logistics Agency awarded a $4,520 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Varivax vaccine with diluents. The award, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at...
- The Defense Logistics Agency awarded a $5,539.20 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and carries no set-aside designation. The contract represents a tactical procurement action supporting the Department of Defense's medical supply...
The Defense Logistics Agency's Medical Supply Chain division awarded a $1,130.56 firm fixed-price purchase order to DMS Pharmaceutical Group Inc. for varicella virus vaccine on December 4, 2025, with a completion date of December 19, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The award supports the Department of Defense's medical supply requirements and represents a discrete delivery order issued under the company's broader Indefinite Delivery Contract relationship with DLA. This purchase order is issued under DMS Pharmaceutical Group Inc.'s single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a $499.999 billion ceiling value and performance period extending through December 31, 2036. PPV-G GEN V represents a $30.3 billion federal acquisition strategy designed to ensure reliable pharmaceutical supply to military healthcare facilities worldwide. As a regional prime vendor contractor, DMS Pharmaceutical Group leverages its established capability to fulfill specialized pharmaceutical requirements across diverse therapeutic categories, with prior delivery orders demonstrating consistent performance in supporting Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/3/25 |